Hematologic Neoplasms: all 1,494 studies
Page 5 of 15. Open to participants first (438), then studies with results posted, then the rest; newest registration first within each.
- Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT RecipientEnrolling by invitationNCT03806764Not applicable
- Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)RecruitingNCT03802773
- Mind-body Medicine for Patients With Malignant Hematological DiseasesRecruitingNCT03735992Not applicable
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic SyndromeRecruitingNCT03670966Phase 1/2
- A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological MalignanciesRecruitingNCT03557619Phase 1
- APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic MalignanciesRecruitingNCT03537482Early Phase 1
- Bleeding In Thrombocytopenia ExplainedRecruitingNCT03505086
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related DiseaseRecruitingNCT03425526Phase 1
- Vaccination for Children of H&O and Their ParentsRecruitingNCT03373656Not applicable
- CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)RecruitingNCT03328078Phase 1/2
- Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBIRecruitingNCT03262220Not applicable
- Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T CellsRecruitingNCT03236129Phase 3
- Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy VolunteersRecruitingNCT03207854
- Cognitive Training Intervention and Attitudes Towards GeneticsRecruitingNCT03094026Not applicable
- UWCCC Molecular Tumor Board RegistryRecruitingNCT03023202
- Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyRecruitingNCT02958462Not applicable
- Elderly CAncer PatientRecruitingNCT02884375
- Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase TrialsRecruitingNCT02534649Not applicable
- Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell StudiesEnrolling by invitationNCT02473757
- Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory FailureRecruitingNCT02464696Not applicable
- Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking StudyRecruitingNCT02457962
- Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical TrialsEnrolling by invitationNCT02315599
- Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical OutcomeRecruitingNCT02269592
- Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic MalignanciesRecruitingNCT02203903Phase 1
- Prospective Cohort With Hemopathy in Languedoc-RoussillonRecruitingNCT02134574
- Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationRecruitingNCT02074839Phase 1
- Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood TransplantsAvailableNCT01881334
- Cologne Cohort of Neutropenic Patients (CoCoNut)RecruitingNCT01821456
- Genomic Profiling in Cancer PatientsRecruitingNCT01775072
- Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramRecruitingNCT01772771
- Infusion of Cell Populations From Unlicensed Umbilical Cord Blood UnitsRecruitingNCT01451502Not applicable
- Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical DonorsRecruitingNCT01374841Phase 2
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)RecruitingNCT01351545
- CIBMTR Research DatabaseRecruitingNCT01166009
- Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyRecruitingNCT00991094
- Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family MembersEnrolling by invitationNCT00071045
- Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
- VitalTraq for the Detection of CRSCompletedNCT06415656Not applicableResults posted
- Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)Active, not recruitingNCT06303167Phase 2Results posted
- Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.TerminatedNCT05579769Phase 2Results posted
- Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University HospitalCompletedNCT05549232Results posted
- Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell TransplantationCompletedNCT05460013Not applicableResults posted
- An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic MalignanciesCompletedNCT05433090Not applicableResults posted
- Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid MalignanciesCompletedNCT05371054Phase 1/2Results posted
- PEA for the Relief of Chemotherapy-Induced Peripheral NeuropathyActive, not recruitingNCT05246670Phase 2Results posted
- Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCTCompletedNCT05216978Not applicableResults posted
- Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) AntibodiesCompletedNCT05148806Results posted
- Positive Psychology Intervention In HSCTCompletedNCT05147311Not applicableResults posted
- Removing Transfusion Dependence as a Barrier to Hospice EnrollmentCompletedNCT05063591Not applicableResults posted
- Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling SurveyCompletedNCT05061095Results posted
- COVID-19 VAX Booster Dosing in Patients With Hematologic MalignanciesCompletedNCT05028374Phase 2Results posted
- A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)CompletedNCT05005442Phase 2Results posted
- PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINCompletedNCT04983901Phase 2Results posted
- Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1TerminatedNCT04874194Phase 1/2Results posted
- Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological MalignanciesTerminatedNCT04865419Phase 1Results posted
- A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor TherapyCompletedNCT04847050Phase 2Results posted
- Lighting Intervention for Cancer-related FatigueCompletedNCT04827446Not applicableResults posted
- Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesTerminatedNCT04789668Phase 1/2Results posted
- Mindfulness and CBT for SleepCompletedNCT04736056Not applicableResults posted
- Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell TransplantationTerminatedNCT04673175Phase 4Results posted
- AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood CancerCompletedNCT04630756Phase 1/2Results posted
- Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving ChemotherapyCompletedNCT04620369Phase 3Results posted
- Study of Benralizumab in People With Skin Side Effects Caused by Cancer TherapiesCompletedNCT04552288Phase 2Results posted
- Effects of Itraconazole and Rifampin on the Blood Tazemetostat LevelsCompletedNCT04537715Phase 1Results posted
- A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRTCompletedNCT04509765Not applicableResults posted
- Radiation Post-CAR T in Refractory LymphomaTerminatedNCT04473937Not applicableResults posted
- Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)Active, not recruitingNCT04439357Phase 2Results posted
- Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)Active, not recruitingNCT04439344Phase 2Results posted
- Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)Active, not recruitingNCT04439331Phase 2Results posted
- Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1)Active, not recruitingNCT04439318Phase 2Results posted
- Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H)Active, not recruitingNCT04439292Phase 2Results posted
- Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)Active, not recruitingNCT04439279Phase 2Results posted
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)Active, not recruitingNCT04439266Phase 2Results posted
- Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G)Active, not recruitingNCT04439253Phase 2Results posted
- Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)Active, not recruitingNCT04439227Phase 2Results posted
- Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)Active, not recruitingNCT04439201Phase 2Results posted
- Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)Active, not recruitingNCT04439188Phase 2Results posted
- Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)Active, not recruitingNCT04439175Phase 2Results posted
- Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)Active, not recruitingNCT04439149Phase 2Results posted
- Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Active, not recruitingNCT04439136Phase 2Results posted
- Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)Active, not recruitingNCT04439123Phase 2Results posted
- Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)Active, not recruitingNCT04439110Phase 2Results posted
- Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory PneumonitisTerminatedNCT04438382Phase 2Results posted
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord TransplantationActive, not recruitingNCT04395222Phase 2Results posted
- Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer PatientsTerminatedNCT04379518Phase 1/2Results posted
- Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19TerminatedNCT04347226Phase 2Results posted
- Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With AlemtuzumabCompletedNCT04312841Phase 2Results posted
- Besponsa Post Marketing Surveillance StudyCompletedNCT04307134Results posted
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseCompletedNCT04294641Phase 2Results posted
- Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological MalignanciesCompletedNCT04260698Phase 3Results posted
- Acalabrutinib for the Treatment of Chronic Graft Versus Host DiseaseActive, not recruitingNCT04198922Phase 2Results posted
- Tildrakizumab for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT04112810Phase 2Results posted
- Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04060277Phase 2Results posted
- Symptom Management for YA Cancer SurvivorsCompletedNCT04035447Not applicableResults posted
- Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical TrialCompletedNCT03892967Not applicableResults posted
- Durvalumab and Tremelimumab for Pediatric MalignanciesActive, not recruitingNCT03837899Phase 1/2Results posted
- A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP)CompletedNCT03823651Not applicableResults posted
- Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic MalignanciesTerminatedNCT03717480Phase 2Results posted
- 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological MalignanciesCompletedNCT03712878Phase 2Results posted